
Will FDA UDI regulation be an opportunity to 3PL service provider?

by
Tejaswini Manjunath
29 September 2013
The UDI regulation announced by FDA will change things around in the supply chain for medical device logistics in USA. The regulation boast of benefits such as traceability, better access to device information, easier recalls and better reverse logistics. This study will identify the implication of UDI on 3PL service provider and how they can encash this opportunity to offer service to medical device manufacturer. Author: Tejaswini Manjunath
Leave a comment
Related Insights:
View All
Get more stories like this
Subscirbe for more news,updates and insights from Beroe